Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV at Center of International Innovation for Technology and Science

🌐 Laotian Times (HK) —
Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV at Center of International Innovation for Technology and Science

AI Summary

Immuno Cure Group inaugurated a research facility at the Center of International Innovation for Technology and Science in Hong Kong to advance its therapeutic DNA vaccine for HIV called ICVAX®. The deployment marks a significant step towards vaccine development success.

Another significant step towards the success of ICVAX® HONG KONG SAR – Media OutReach Newswire – 27 May 2026 – Immuno Cure Group (“Immuno Cure“), headquartered at Hong Kong Science Park, is pleased to announce the inauguration of the research facility for its HIV therapeutic DNA vaccine (“ICVAX®“) at the Center of International Innovation for […]

Health AI & Tech Immuno Cure HIV vaccine ICVAX DNA vaccine Hong Kong Science Park research facility vaccine development

Read original source →